Retention of metabolites of 2′,3′-didehydro-3′-deoxy- 4′-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3317-3324

  Wang, Xin ^a   Tanaka, Hiromichi ^b   Baba, Masanori ^c   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIHEHYDRO 3' DEOXY 4' ETHYNYLTHYMIDINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 4; NUCLEOSIDE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DRUG RETENTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPERATURE DEPENDENCE;

ANTI-HIV AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPYRIDAMOLE; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; STAVUDINE; THYMIDINE; ZIDOVUDINE;

EID: 67749095978     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00302-09     Document Type: Article

References (25)

1. Cheng, Y. C., and W. H. Prusoff. 1974. A new rapid assay for measuring deoxycytidylate- and deoxythymidylate-kinase activities. Anal. Biochem. 60: 545-550.
2. Dahlig-Harley, E., Y. Eilam, A. R. Paterson, and C. E. Cass. 1981. Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside-transport mechanism of HeLa cells. Biochem. J. 200:295-305.
3. Dutschman, G. E., E. G. Bridges, S. H. Liu, E. Gullen, X. Guo, M. Kukhanova, and Y. C. Cheng. 1998. Metabolism of 2′,3′-dideoxy- 2′, 3′-didehydro-β-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus β-D(+) nucleoside analogs in vitro. Antimicrob. Agents Chemother. 42:1799-1804.
4. Dutschman, G. E., S. P. Grill, E. A. Gullen, K. Haraguchi, S. Takeda, H. Tanaka, M. Baba, and Y. C. Cheng. 2004. Novel 4′-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity. Antimicrob. Agents Chemother. 48:1640-1646.
5. Gathe, J. C., Jr., P. Ive, R. Wood, D. Schurmann, N. C. Bellos, E. DeJesus, A. Gladysz, C. Garris, and J. Yeo. 2004. SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients. AIDS 18:1529-1537.
6. Haraguchi, K., S. Takeda, H. Tanaka, T. Nitanda, M. Baba, G. E. Dutschman, and Y. C. Cheng. 2003. Synthesis of a highly active new anti-HIV agent 2′,3′-didehydro-3′-deoxy-4′-ethynylthymidine. Bioorg. Med. Chem. Lett. 13:3775-3777.
7. Hsu, C. H., R. Hu, G. E. Dutschman, G. Yang, P. Krishnan, H. Tanaka, M. Baba, and Y. C. Cheng. 2007. Comparison of the phosphorylation of 4′-ethynyl 2′,3′-dihydro-3′-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs. Antimicrob. Agents Chemother. 51:1687-1693.
8. Johnson, A. A., A. S. Ray, J. Hanes, Z. Suo, J. M. Colacino, K. S. Anderson, and K. A. Johnson. 2001. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem. 276:40847- 40857.
9. Kakuda, T. N. 2000. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin. Ther. 22:685-708.
10. Liou, J. Y., G. E. Dutschman, W. Lam, Z. Jiang, and Y. C. Cheng. 2002. Characterization of human UMP/CMP kinase and its phosphorylation of Dand L-form deoxycytidine analogue monophosphates. Cancer Res. 62:1624-1631.
11. Liu, S. H., K. L. Grove, and Y. C. Cheng. 1998. Unique metabolism of a novel antiviral L-nucleoside analog, 2′-fluoro-5-methyl-β-L- arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase. Antimicrob. Agents Chemother. 42:833-839.
12. Nakata, H., M. Amano, Y. Koh, E. Kodama, G. Yang, C. M. Bailey, S. Kohgo, H. Hayakawa, M. Matsuoka, K. S. Anderson, Y. C. Cheng, and H. Mitsuya. 2007. Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4′-ethynyl-2-fluoro-2′-deoxyadenosine. Antimicrob. Agents Chemother. 51:2701-2708.
13. Nitanda, T., X. Wang, H. Kumamoto, K. Haraguchi, H. Tanaka, Y. C. Cheng, and M. Baba. 2005. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2′,3′-didehydro-3′-deoxy-4′- ethynylthymidine in vitro. Antimicrob. Agents Chemother. 49:3355-3360.
14. Paintsil, E., G. E. Dutschman, R. Hu, S. P. Grill, W. Lam, M. Baba, H. Tanaka, and Y. C. Cheng. 2007. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2′,3′-didehydro- 3′-deoxy-4′-ethynylthymidine, a novel thymidine analog. Antimicrob. Agents Chemother. 51:3870-3879.
15. Pastor-Anglada, M., P. Cano-Soldado, M. Molina-Arcas, M. P. Lostao, I. Larrayoz, J. Martinez-Picado, and F. J. Casado. 2005. Cell entry and export of nucleoside analogues. Virus Res. 107:151-164.
16. Peng, X. X., Z. Shi, V. L. Damaraju, X. C. Huang, G. D. Kruh, H. C. Wu, Y. Zhou, A. Tiwari, L. Fu, C. E. Cass, and Z. S. Chen. 2008. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Leuk. Res. 32:799-809.
17. Podgorska, M., K. Kocbuch, and T. Pawelczyk. 2005. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim. Pol. 52:749-758.
18. Pomerantz, R. J., and D. L. Horn. 2003. Twenty years of therapy for HIV-1 infection. Nat. Med. 9:867-873.
19. Robbins, B. L., R. V. Srinivas, C. Kim, N. Bischofberger, and A. Fridland. 1998. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl) adenine (PMPA), bis(isopropyloxymethylcarbonyl)-PMPA. Antimicrob. Agents Chemother. 42:612-617.
20. Schuetz, J. D., M. C. Connelly, D. Sun, S. G. Paibir, P. M. Flynn, R. V. Srinivas, A. Kumar, and A. Fridland. 1999. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 5:1048-1051.
21. Sosa, N., C. Hill-Zabala, E. Dejesus, G. Herrera, A. Florance, M. Watson, C. Vavro, and M. Shaefer. 2005. Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL). J. Acquir. Immune Defic. Syndr. 40:422-427.
22. Wang, X., T. Furukawa, T. Nitanda, M. Okamoto, Y. Sugimoto, S. Akiyama, and M. Baba. 2003. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol. Pharmacol. 63:65-72.
23. Wang, X., T. Nitanda, M. Shi, M. Okamoto, T. Furukawa, Y. Sugimoto, S. Akiyama, and M. Baba. 2004. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem. Pharmacol. 68:1363-1370.
24. Yang, G., G. E. Dutschman, C. J. Wang, H. Tanaka, M. Baba, K. S. Anderson, and Y. C. Cheng. 2007. Highly selective action of triphosphate metabolite of 4′-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. Antivir. Res. 73:185-191.
25. Yeni, P. G., S. M. Hammer, M. S. Hirsch, M. S. Saag, M. Schechter, C. C. Carpenter, M. A. Fischl, J. M. Gatell, B. G. Gazzard, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, R. T. Schooley, M. A. Thompson, S. Vella, and P. A. Volberding. 2004. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society - USA Panel. JAMA 292:251-265.